.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Medtronic
Covington
McKesson
Merck
Baxter
Dow
UBS
McKinsey
Deloitte

Generated: June 28, 2017

DrugPatentWatch Database Preview

SUBUTEX Drug Profile

« Back to Dashboard

Which patents cover Subutex, and when can generic versions of Subutex launch?

Subutex is a drug marketed by Indivior Inc and is included in one NDA.

The generic ingredient in SUBUTEX is buprenorphine hydrochloride. There are twenty-eight drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the buprenorphine hydrochloride profile page.

Summary for Tradename: SUBUTEX

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list16
Clinical Trials: see list30
Patent Applications: see list702
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SUBUTEX at DailyMed

Pharmacology for Tradename: SUBUTEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Indivior Inc
SUBUTEX
buprenorphine hydrochloride
TABLET;SUBLINGUAL020732-002Oct 8, 2002DISCNYesNo► Subscribe► Subscribe
Indivior Inc
SUBUTEX
buprenorphine hydrochloride
TABLET;SUBLINGUAL020732-003Oct 8, 2002DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Deloitte
Chinese Patent Office
US Army
Medtronic
QuintilesIMS
Citi
UBS
Colorcon
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot